Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China

NCT06422117 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Neuropathic Pain

Interventions

DRUG: HSK16149 20mg-40mg BID
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.